P3 Health Partners

PIII · NASDAQ

$3.97+$0.16 (+4.20%)TodayMarket closed ·
Prev close $3.81

About PIII

P3 Health Partners, Inc. is a population health care management company, which engages in the provision of professional support services to doctors and clinicians. The company is headquartered in Chicago, Illinois and currently employs 320 full-time employees. The company went IPO on 2021-02-10. The firm is a team of doctors, clinicians and healthcare professionals with a shared passion for delivering value-based care (VBC). Its platform focuses on Medicare Advantage and manages the needs of its members through subscription-like per-member-per-month (PMPM) arrangements with health plans or payors. Its technology platform, P3 Technology/Health Hub, enables physicians, care teams, patients and their family members to engage in the care journey. P3 Technology/Health Hub integrates clinical and claims data from disparate data points each month from payors, outpatient and inpatient facilities and other ancillary care settings. The company uses P3 Technology/Health Hub at the time of patient onboarding, able to assign patient risk levels using its proprietary risk stratification tool that leverages multiple parameters to prioritize patients who require additional resources.

Employees
320
Headquarters
Chicago, Illinois
Listed
Feb 10, 2021
Sector
Health Care
Industry
Health Care Providers & Services

PIII key statistics

Market cap
29.24M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
12.91K
Volume
9.54K
Open price
$3.82
High today
$4.27
Low today
$3.88
52 Week high
$16.89
52 Week low
$1.52

P3 Health Partners (PIII) at a glance

P3 Health Partners (PIII) last traded at $3.97, with a market cap of 29.24M and a price-to-earnings ratio of 0.00.

Today the stock has traded between $3.88 and $4.27. The current price is 2.3% above the day's low and 7.0% below its high.

Volume so far is 9.54K shares, below the average of 12.91K shares a day.

Over the past year P3 Health Partners has ranged from $1.52 to $16.89, and now sits 16% of the way up that range.

P3 Health Partners met or beat analyst EPS estimates in 3 of the last 8 quarters. In Q2 FY26 it reported -$0.63 per share against an estimate of -$1.93.

The average analyst price target is $18.36, 362.5% above the current price, from 3 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

33%of 3 analyst ratings say Buy
  • Buy33.3%
  • Hold66.7%
  • Sell0.0%
Price target · 4 analystsAvg $18.36
Low
$13.13
Now
$3.97
High
$24.15

PIII earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 3 of the last 8 quarters, by 69.1% on average.

  1. Q3 FY24: reported -$14.50 per share against an estimate of -$1.91
  2. Q4 FY24: reported -$19.50 per share against an estimate of -$4.18
  3. Q1 FY25: reported -$6.28 per share against an estimate of -$9.09
  4. Q2 FY25: reported -$6.23 per share against an estimate of -$4.83
  5. Q3 FY25: reported -$9.67 per share against an estimate of -$6.16
  6. Q4 FY25: reported -$23.02 per share against an estimate of -$9.65
  7. Q1 FY26: reported $0.32 per share against an estimate of -$3.58
  8. Q2 FY26: reported -$0.63 per share against an estimate of -$1.93

PIII news

  • Press releaseBusiness Wire

    P3 Health Partners Inc. Announces Appointment of Chief Clinical Officer

  • 12 Health Care Stocks Moving In Monday's After-Market Session

  • Press releaseBusiness Wire

    P3 Health Partners Announces Second Quarter 2026 Results

  • Press releaseBusiness Wire

    P3 Health Partners Schedules Second Quarter 2026 Earnings Release and Conference Call

  • 12 Health Care Stocks Moving In Monday's Pre-Market Session

  • 12 Health Care Stocks Moving In Friday's After-Market Session

  • 12 Health Care Stocks Moving In Friday's Intraday Session

  • 12 Health Care Stocks Moving In Friday's Pre-Market Session

Similar companies

Companies in the same industry as P3 Health Partners

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.